These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Studying cellular heterogeneity and drug sensitivity in colorectal cancer using organoid technology. Sasaki N; Clevers H Curr Opin Genet Dev; 2018 Oct; 52():117-122. PubMed ID: 30261425 [TBL] [Abstract][Full Text] [Related]
5. The use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis. Chowdhury R; Ganeshan B; Irshad S; Lawler K; Eisenblätter M; Milewicz H; Rodriguez-Justo M; Miles K; Ellis P; Groves A; Punwani S; Ng T Br J Radiol; 2014 Jun; 87(1038):20140065. PubMed ID: 24597512 [TBL] [Abstract][Full Text] [Related]
6. [Intra-tumour heterogeneity in colorectal cancer]. Wenzel C Pathologe; 2019 Sep; 40(5):527-528. PubMed ID: 31414178 [No Abstract] [Full Text] [Related]
7. Targeting the Colorectal Cancer Stem Cell. Medema JP N Engl J Med; 2017 Aug; 377(9):888-890. PubMed ID: 28854096 [No Abstract] [Full Text] [Related]
8. Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps. Chen B; Scurrah CR; McKinley ET; Simmons AJ; Ramirez-Solano MA; Zhu X; Markham NO; Heiser CN; Vega PN; Rolong A; Kim H; Sheng Q; Drewes JL; Zhou Y; Southard-Smith AN; Xu Y; Ro J; Jones AL; Revetta F; Berry LD; Niitsu H; Islam M; Pelka K; Hofree M; Chen JH; Sarkizova S; Ng K; Giannakis M; Boland GM; Aguirre AJ; Anderson AC; Rozenblatt-Rosen O; Regev A; Hacohen N; Kawasaki K; Sato T; Goettel JA; Grady WM; Zheng W; Washington MK; Cai Q; Sears CL; Goldenring JR; Franklin JL; Su T; Huh WJ; Vandekar S; Roland JT; Liu Q; Coffey RJ; Shrubsole MJ; Lau KS Cell; 2021 Dec; 184(26):6262-6280.e26. PubMed ID: 34910928 [TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer. Coppedè F; Lopomo A; Spisni R; Migliore L World J Gastroenterol; 2014 Jan; 20(4):943-56. PubMed ID: 24574767 [TBL] [Abstract][Full Text] [Related]
10. ICGC-ARGO precision medicine: an update on targeted therapy based on longitudinal analysis of tumour heterogeneity and evolution in colorectal cancer. Kotani D; Nakamura Y; Fujisawa T; Bando H; Sakamoto N; Johns AL; Park K; ; Casolino R; Yoshino T; Biankin AV Lancet Oncol; 2023 Jan; 24(1):20-21. PubMed ID: 36603918 [No Abstract] [Full Text] [Related]
11. ICGC-ARGO precision medicine: targeted therapy according to longitudinal assessment of tumour heterogeneity in colorectal cancer. Kotani D; Nakamura Y; Fujisawa T; Bando H; Sakamoto N; Johns AL; Park K; ; Casolino R; Yoshino T; Biankin AV Lancet Oncol; 2022 Apr; 23(4):463-464. PubMed ID: 35358454 [No Abstract] [Full Text] [Related]
12. Single-molecule genomic data delineate patient-specific tumor profiles and cancer stem cell organization. Sottoriva A; Spiteri I; Shibata D; Curtis C; Tavaré S Cancer Res; 2013 Jan; 73(1):41-9. PubMed ID: 23090114 [TBL] [Abstract][Full Text] [Related]
13. Surgical management of extra-regional lymph node metastasis in colorectal cancer. Albandar MH; Cho MS; Bae SU; Kim NK Expert Rev Anticancer Ther; 2016 May; 16(5):503-13. PubMed ID: 26950286 [TBL] [Abstract][Full Text] [Related]
15. Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in Grillet F; Bayet E; Villeronce O; Zappia L; Lagerqvist EL; Lunke S; Charafe-Jauffret E; Pham K; Molck C; Rolland N; Bourgaux JF; Prudhomme M; Philippe C; Bravo S; Boyer JC; Canterel-Thouennon L; Taylor GR; Hsu A; Pascussi JM; Hollande F; Pannequin J Gut; 2017 Oct; 66(10):1802-1810. PubMed ID: 27456153 [TBL] [Abstract][Full Text] [Related]
16. KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/β-catenin signalling. Li J; Yu B; Deng P; Cheng Y; Yu Y; Kevork K; Ramadoss S; Ding X; Li X; Wang CY Nat Commun; 2017 Apr; 8():15146. PubMed ID: 28440295 [TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine? Molinari C; Marisi G; Passardi A; Matteucci L; De Maio G; Ulivi P Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477151 [TBL] [Abstract][Full Text] [Related]
18. Emerging Prospects for the Study of Colorectal Cancer Stem Cells using Patient-derived Organoids. Ding L; Yang Y; Lu Q; Cao Z; Weygant N Curr Cancer Drug Targets; 2022; 22(3):195-208. PubMed ID: 35078398 [TBL] [Abstract][Full Text] [Related]
19. PCGF1 promotes epigenetic activation of stemness markers and colorectal cancer stem cell enrichment. Ji G; Zhou W; Du J; Zhou J; Wu D; Zhao M; Yang L; Hao A Cell Death Dis; 2021 Jun; 12(7):633. PubMed ID: 34148069 [TBL] [Abstract][Full Text] [Related]
20. G9a Is SETting the Stage for Colorectal Oncogenesis. Bergin CJ; Benoit YD Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32512705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]